Arlington Partners LLC Organon & Co. Transaction History

Arlington Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$16.59 - $23.77 $398 - $570	-24 Reduced 85.71%	4 $0
Q1 2023 Apr 26, 2023	SELL	$21.42 - $32.08 $728 - $1,090	-34 Reduced 54.84%	28 $0
Q4 2022 Jan 19, 2023	BUY	$23.31 - $28.61 $885 - $1,087	38 Added 158.33%	62 $2,000
Q2 2022 Jul 25, 2022	BUY	$31.66 - $38.9 $759 - $933	24 New	24 $1,000
Q1 2022 Apr 14, 2022	SELL	$30.45 - $39.36 $2,679 - $3,463	-88 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$28.67 - $37.13 $1,863 - $2,413	-65 Reduced 42.48%	88 $3,000
Q3 2021 Oct 15, 2021	BUY	$28.63 - $35.64 $4,380 - $5,452	153 New	153 $5,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.